Cryo-Cell International (CCEL) Stock: Buy, Sell, or Hold?
CCEL - Cryo-Cell International Inc.
$4.49
-0.19 (-4.06%)
âŧ
5d:
+23.01%
30d:
+12.53%
90d:
+29.77%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Oct 21, 2026
0d
Get Alerted When CCEL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: CCEL is fairly priced but lacks strong directional signals. At 5.9% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: CCEL is fairly priced but lacks strong directional signals. At 5.9% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: CCEL is currently trading at $4.49, which is considered slightly high relative to its 30-day fair value range of $3.91 to $4.50. From a valuation perspective, the stock is trading at a premium (Forward PE: 224.5) compared to its historical average (188.8). At these levels, the market is pricing in 5.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CCEL is in a uptrend. Immediate support is located at $3.65, while resistance sits at $4.89. Short-term momentum is weak, with the stock down 4.1% recently.
Market Sentiment: CCEL scores 31/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.50 (+89.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CCEL is in a uptrend. Immediate support is located at $3.65, while resistance sits at $4.89. Short-term momentum is weak, with the stock down 4.1% recently.
Market Sentiment: CCEL scores 31/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.50 (+89.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$3.91 -
$4.50
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
37.1%
All Signals
- BEARISH: Weak technical setup (31/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.1%)
- BULLISH: Trading 89.3% below Wall St target ($8.50)
- NEUTRAL: Trading at premium valuation - market expects 5.9% growth which is achievable
- WARNING: Composite score 39/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.91 -
$4.50
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$3.65
Resistance Level
$4.89
Current Trend
Uptrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
224.50
Wall Street Target
$8.50
(+89.3%)
Earnings Growth (YoY)
75.1%
Profit Margin
-6.2%
Valuation Premium vs History
+5.9% premium
PE vs Historical
224.5 vs 188.8
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.9%
(market-implied from PE analysis)
1-Year Target
$4.75
(+6%)
2-Year Target
$5.04
(+12%)
3-Year Target
$5.33
(+19%)
3-Yr Target (if PE normalizes)
(PE: 225â189)
PE COMPRESSION
$4.48
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 224.5, Growth: -81.8%)
$3.27
(+-27%)
Base:
(SPY PE: 19.9, Growth: -81.8%)
$0.29
(-94%)
Bear:
(PE: 16.9, Growth: -81.8%)
$0.25
(-95%)
Share & Embed Analysis
Last updated: October 22, 2026 7:27 PM ET
Data refreshes hourly during market hours. Next update: 8:27 PM
Data refreshes hourly during market hours. Next update: 8:27 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CCEL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare CorporaâĻ |
STRONG BUY
23 analysts |
$286 | 54 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
26 analysts |
$461 | 50 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
16 analysts |
$24 | 61 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
13 analysts |
$148 | 60 HOLD |
|
GRDN
Guardian Pharmacy ServicâĻ |
STRONG BUY
7 analysts |
$50 | 60 BUY |
